HEXPOL Balanced Scorecard

HEXPOL Balanced Scorecard

Fully Editable

Tailor To Your Needs In Excel Or Sheets

Professional Design

Trusted, Industry-Standard Templates

Pre-Built

For Quick And Efficient Use

No Expertise Is Needed

Easy To Follow

HEXPOL Bundle

Get Full Bundle:
$15 $10
$15 $10
$15 $10
$15 $10
$15 $10
Icon

Go Beyond the Preview – Access the Full Balanced Scorecard

This HEXPOL Balanced Scorecard Analysis gives you a clear view of the company's financial, customer, internal process, and learning and growth priorities in one practical framework. The page already shows a real preview of the actual analysis, so you can review the content before buying. Purchase the full version to get the complete ready-to-use report.

Benefits

Icon

Customer Focus

Customer focus matters at HEXPOL because custom compounds must match each customer spec, so the scorecard should track on-time delivery, complaint closure time, and qualification success. In FY2025, these metrics matter most in automotive, construction, consumer goods, and medical uses, where a missed spec can delay launch or stop production. A tight customer scorecard also supports repeat business and lowers rework.

Icon

Quality Control

Quality control is a real edge for HEXPOL because polymers and gaskets must hold tight specs across volume. With HEXPOL reporting about SEK 22.4 billion in net sales in 2024, even small scrap cuts can protect margin and repeat orders. Tracking scrap rate, first-pass yield, and defect escapes helps keep rework down and steadies output in demanding end markets.

Explore a Preview
Icon

Innovation Pipeline

HEXPOL competes on tailored compounds, so its innovation pipeline has direct value in 2025, when management had to turn R&D into faster launches and more qualified products. A balanced scorecard can track R&D spend versus development cycle time, qualification rate, and new-product revenue, showing whether lab work is creating sales. That matters because even a small lift in launch speed can protect margins in a business built on customer-specific solutions.

Icon

Plant Efficiency

HEXPOL's global plant network makes efficiency a direct margin lever. In 2025, scorecard tracking of asset utilization, conversion cost, energy intensity, and inventory turns helps keep output flexible while controlling unit costs. That matters when lines switch between standard compounds and customer-specific formulas, because setup time and scrap can rise fast. Strong plant efficiency protects service levels and cash flow at the same time.

Icon

Global Alignment

Global alignment matters at HEXPOL because the group serves many industries and regions, so one balanced scorecard helps leaders compare plants on the same metrics. It gives one language for capital calls, margin goals, and quality control, which matters when 2025 group decisions need to cut across multiple sites. That lowers the risk of local wins masking weaker group results.

Icon

HEXPOL's Scale Turns Small Efficiency Gains Into Big FY2025 Profit

HEXPOL's main benefits are tighter margins, faster launches, and steadier service, all driven by customer-specific compounds and strict quality control. With FY2024 net sales of SEK 22.4 billion, small gains in scrap, first-pass yield, and plant use can have a large profit impact in FY2025.

Benefit FY2024/25 data
Scale SEK 22.4bn sales

What is included in the product

Word Icon Detailed Word Document
Maps HEXPOL's strategic performance across financial, customer, internal process, and learning and growth priorities
Plus Icon
Excel Icon Editable Excel File
Provides a clear HEXPOL Balanced Scorecard snapshot to quickly pinpoint performance gaps across financial, customer, process, and growth priorities.

Drawbacks

Icon

Complex Mix

HEXPOL's 2025 mix across medical, construction, consumer, and other end markets makes one balanced scorecard too blunt. A medical-grade plant needs tighter defect and traceability targets than a construction line, so one generic set of KPIs can hide scrap, yield, and complaint problems. If the scorecard does not split targets by plant and market, weak spots can stay buried until margins slip.

Icon

Uneven Sites

HEXPOL's global plant network can be hard to compare because sites often run different product mixes, equipment ages, and customer specs, so a high score may simply reflect an easier operation. In 2025, that matters more because cost and service pressure is tied to each site's own load and margin profile, not just output volume. Without normalization, the scorecard can reward the least complex plant instead of the most strategic one.

Explore a Preview
Icon

Data Burden

HEXPOL's Balanced Scorecard can be data-heavy because it pulls from operations, sales, quality, and HR across multiple geographies. In 2025, that means more time spent reconciling site-level inputs and checking consistency before managers can trust the metrics. If data hygiene is weak, the scorecard becomes a reporting task, not a control tool.

Icon

Slow Signals

At HEXPOL, customer satisfaction, new-product qualification, and profitability can lag weeks or months behind a line issue, so a defect or downtime spike may stay hidden for a full reporting cycle. That weakens the scorecard as an early-warning tool because managers may see the problem only after it has already hit delivery, scrap, or margin. In a 2025 setting with tight cost pressure, those delays can let small faults turn into larger losses before action starts.

Icon

Throughput Pressure

Throughput pressure can push HEXPOL managers to favor steady line speed over hard custom work. That is risky because HEXPOL wins by solving complex polymer and compounding problems, not just by running assets fast. A narrow output focus can hurt innovation and customer intimacy, and over time that can cost more than a few extra tons of volume.

Icon

HEXPOL's scorecard can mask plant-level quality risk in 2025

HEXPOL's 2025 balanced scorecard can blur plant-level risk because medical, construction, and consumer operations need different defect, yield, and traceability targets. A single KPI set can hide scrap or complaint spikes, especially when site complexity and customer specs differ. Slow quality and customer data also weaken early warning. Output focus can still crowd out innovation.

Drawback 2025 impact
Mixed end markets One KPI set can hide weak spots
Site differences Scores may favor easier plants
Data lag Problems surface after margins slip

What You See Is What You Get
HEXPOL Reference Sources

This HEXPOL Balanced Scorecard Analysis preview is the exact document you'll receive after purchase. What you see here is pulled directly from the full report, so there are no surprises. Once you complete checkout, the complete Balanced Scorecard analysis becomes available in full detail.

Explore a Preview

Frequently Asked Questions

It measures whether customer-specific growth is translating into reliable execution. For HEXPOL, the most useful indicators are on-time delivery, complaint rates, first-pass yield, and new-product qualification time. Those four metrics connect tailored polymer work to outcomes customers actually feel: consistent quality, technical responsiveness, and fewer production disruptions.

Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.